Harrogate-based manufacturer of medical grade orthopaedic supports, Neo G, have appointed Dan Jones as Chief Executive Officer.
Neo G announced the appointment as the firm relocated their offices and warehouse to a larger space to accommodate their expanding team and to meet the growing demand from international pharmaceutical retailers including Boots, Tesco, Walgreens and CVS.
Having been with the company since 2014, Jones will be taking over the role of CEO from founder, Paul Starkey, who will move into the position of chairman.
As commercial director, Jones has already overseen large growth in the company.
Starkey says: “Dan has demonstrated his commitment to Neo G and our Medical Grade strategy. Over the last seven years, he has helped define and establish the company as the no. 1 brand in the UK, and the fastest growing brand in the US.
“I am very proud of the way he has grown in the company and adopted the Neo G mantra as his own. I know he will take Neo G to new heights, and I will do everything I can as the chairman to support all of his and the teams’ efforts.”
Jones added: “I’m proud of what we as a team have achieved together in this time, especially through the pandemic. I look forward to continuing working with the team towards making the company even stronger going forward.”
The appointment of Jones as CEO follows the relocation of the firm to a fully refurbished office.
Group finance director, Chris Brookes, said: “The new offices look amazing and make for a fresh, contemporary and organised space to work from. They’ve been designed not just to look great, but to be safer for everyone to enjoy, with measures including a newly installed fresh air recirculation system.
“The new innovation room and design studio allow our in-house experts to stay on the cutting edge of the industry and consistently produce new orthopaedic solutions.”
The move to a larger office and warehouse space is in line with Neo G’s expansion and plans to create 30 jobs over the coming years as growth in the UK, US and Europe are forecast for the Yorkshire firm.
